Publication:
Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.

Simple item page
dc.contributor.authorAlvarez, R
dc.contributor.authorMusteanu, M
dc.contributor.authorGarcia-Garcia, E
dc.contributor.authorLopez-Casas, P P
dc.contributor.authorMegias, D
dc.contributor.authorGuerra, Carmen
dc.contributor.authorMuñoz, M
dc.contributor.authorQuijano, Y
dc.contributor.authorCubillo, A
dc.contributor.authorRodriguez-Pascual, J
dc.contributor.authorPlaza, C
dc.contributor.authorde Vicente, E
dc.contributor.authorPrados, S
dc.contributor.authorTabernero, S
dc.contributor.authorBarbacid, Mariano
dc.contributor.authorLopez-Rios, F
dc.contributor.authorHidalgo, M
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.date.accessioned2024-09-16T08:16:53Z
dc.date.available2024-09-16T08:16:53Z
dc.date.issued2014-10-14
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipThis study was supported by the Fondo de Investigaciones Sanitarias (FIS) PI10-01996 and Celgene Inc. to MH; the European Research Council (ERC-AG/250297-RAS AHEAD) and Spanish Ministry of Economy andCompetitiveness (SAF2011-30173) to MBes_ES
dc.format.number8es_ES
dc.format.page1677es_ES
dc.format.volume111es_ES
dc.identifier.citationBr J Cancer . 2014 ;111(8):1677-8es_ES
dc.identifier.doi10.1038/bjc.2014.129es_ES
dc.identifier.e-issn1532-1827es_ES
dc.identifier.journalBritish journal of canceres_ES
dc.identifier.pubmedID24642623es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23067
dc.language.isoenges_ES
dc.publisherSpringer
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MICINN/ES/SAF2011-30173es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/EC/FP7/250297/EUes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI10-01996es_ES
dc.relation.publisherversionhttps://doi.org/10.1038/bjc.2014.129es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Oncología Experimentales_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAdenocarcinomaes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshAntineoplastic Combined Chemotherapy Protocolses_ES
dc.subject.meshFemalees_ES
dc.subject.meshFibroblastses_ES
dc.subject.meshHumanses_ES
dc.subject.meshMalees_ES
dc.subject.meshPancreatic Neoplasmses_ES
dc.titleReply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.es_ES
dc.typeletter to the editores_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione3ceecfe-c5d7-442a-97d8-087e6883b1b2
relation.isAuthorOfPublication728b1f96-276b-4ab5-8640-8964fb72939f
relation.isAuthorOfPublication.latestForDiscoverye3ceecfe-c5d7-442a-97d8-087e6883b1b2
relation.isFunderOfPublicationcb2ee04a-8d42-4a64-b3f6-3c156f222b35
relation.isFunderOfPublication.latestForDiscoverycb2ee04a-8d42-4a64-b3f6-3c156f222b35
relation.isPublisherOfPublication8d558850-2ef2-4d1e-b0e1-4e5591ab6288
relation.isPublisherOfPublication.latestForDiscovery8d558850-2ef2-4d1e-b0e1-4e5591ab6288

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
replycommentsonstromal_2014.pdf
Size:
163.62 KB
Format:
Adobe Portable Document Format
Download

Collections

Grupos de investigación